Searched for
ALEMBIC LIMITED
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...
- Alembic Pharma plans to launch 25 drugs in US generics segment this fiscalThe Vadodara-based drug maker, which has been around for over a century, is a late entrant in the US market. It has more than made up for i...
- Neutral on Alembic Pharma, target price Rs 970: Motilal OswalAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 16891.65 Crore) operating in P...
- Stocks in the news: NIIT Tech, Wockhardt, Lakshmi Vilas Bank, GVK Infra, Vodafone IdeaMacquarie has initiated coverage on Jyothy Laboratories with Outperform rating.
- Alembic Pharma gets USFDA nod for Acyclovir ointmentThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembi...
- Stock pick of the week: What makes Alembic Pharma a good bet in muted pharma industryInvestment in R&D and new facilities focus on exports, new launches and likely growth in revenue of about 35% in the coming years has made ...
- Alembic Pharma Q3 net profit at Rs 86.55 croreConsolidated total income from operations during the quarter under review also fell to Rs 777.03 crore from Rs 930.89 crore a year ago.
- Alembic Pharma Q2 net dips 58% to Rs 119.83 crThe consolidated total income from operations also declined to Rs 879.42 crore for the quarter under consideration as against Rs 1,018.07 c...
- Bullish on MCX and Alembic: G Chokkalingam, Equinomics Research & AdvisoryAn important point is that in April-June quarter this year, for the first time in the recent time after the taxes were imposed on the trans...
- Alembic Q3 net zooms over two-fold to Rs 30.84 crThe company's total income stood at Rs 366.27 crore for the third quarter ended December 31, 2010, compared to Rs 300.90 crore in the same ...
Load More
